An experienced leader with 20+ years commercializing medicines across primary and specialty care. Skilled in high-level strategic thinking and overcoming execution obstacles, with a proven record of co-creating and delivering tailored solutions for external stakeholders. Committed to fostering inclusive cultures, developing talent, and building empowering work environments. Aspires to enhance the Canadian health system and improve patient outcomes through innovative partnerships and coalitions.

As General Manager at IQVIA Canada, Mark oversees IQVIA’s thought leadership strategy and initiatives and leads its marketing and corporate communications teams. He also provides consulting leadership to companies in the pharmaceutical, biotech, and government sectors across IQVIA’s Consulting, Analytics, Market Access, and Technology Solutions. Mark has held senior roles as President, and Vice President Commercial at several leading pharmaceutical, biotech, technology, and start-up companies. A business leader with more than 25 years of experience in the pharmaceutical, information technology, and consulting sectors, Mark brings product launch, market access and global marketing expertise across multiple therapeutic areas to his work at IQVIA.

Jennifer is the Director of Communications at PAAB. She has a degree in Biology and Pharmacology from McMaster University and a Global Executive MBA in Health and Life Science from Rotman School of Management. She has been in the pharmaceutical industry for over 15 years with time in Medical Information and Health Outcomes and Pricing before transitioning to PAAB. She has chaired several industry committees including the recent RWE committee. Outside her role at PAAB, she is an active member on the OPMA board and can be found running and cycling around the city in her down time.

With over 20 years in brand and marketing strategy, Jacob has led brand strategy in DTC, HCP, and digital AORs across pharma brands. As an early adopter of generative AI for marketers, he spearheads initiatives that merge marketing strategy and creative expertise with data science to redefine pharma marketing, setting new benchmarks for impactful brand growth.

Patrick Glinski, Co-Founder of ComposeHealth.ai and President of Normative Innovation, is an expert in human-centered design and change management for technology adoption. With 20 years in agency and consulting, he has worked with top life sciences brands and, more recently, with Canada’s Digital Supercluster on AI maturity and use case identification.

Kevin brings over 25 years of sales and insights experience in Consumer Packaged Goods (CPG).

Through his 23 years at PepsiCo, Kevin had the opportunity to work across food and beverage categories and to manage and work with customers across all channels. His experience at PepsiCo includes 7 years leading the Category Insights Team for beverages, where he collaborated with retailers to implement insights-led solutions to drive joint business plan results.

Kevin’s mandate as Senior Vice President and Sales Team Leader of the CPG team is to work with Environics Analytics’ (EA) clients and strategic partners to help them become more data-driven, leveraging deeper insights and practical applications that get measurable results. This includes leveraging clients’ first-party data in combination with EA’s databases (including big data) to better understand and profile customers, quantify the market potential, locate high-value prospects and activate the insights across the enterprise, including in digital and traditional media.

Kevin holds degrees from Queen’s University, the University of Windsor and York University.

Matthew is a Canadian healthcare executive with more than 20 years of experience working in both the public and private sector. He has worked as an expert advisor, founded a boutique healthcare analytics firm, been an Associate Partner with a leading healthcare consulting practice, and held a variety of roles at the Ontario Ministry of Health and Long-Term Care. As the General Manager of IQVIA Canada’s Consulting & Analytics division and its Technology Solutions division, Matthew and his team support the pharmaceutical industry with novel commercial strategies and technology solutions to support product launch, segmentation, forecasting, reporting, customer relationship management, digital marketing, and advanced analytics. Over the past nine years, Matthew also leads the IQVIA Canada Government and Healthcare Providers practice in Canada.

Jessica brings close to 20 years of experience consulting in the pharmaceutical and biotech industries in Canada, US and globally. With a background in learning and development, she has bridged into marketing to help clients align brand strategy with field execution. As CEO of Metrix since 2017, she drives company innovation while fostering a thriving organization. An active industry contributor, she has spoken at conferences across North America, and is currently a board member for the LIfe Sciences Trainers and Educators Network. She draws inspiration from diverse industries to shape her leadership and strategic approach.